|
|
Pituitary adenylate cyclase-activating polypeptide type 1 receptor signaling evokes long-lasting nociceptive behaviors through the activation of spinal astrocytes in mice
|
|
|
|
|
نویسنده
|
ohnou t. ,yokai m. ,kurihara t. ,hasegawa-moriyama m. ,shimizu t. ,inoue k. ,kambe y. ,kanmura y. ,miyata a.
|
منبع
|
journal of pharmacological sciences - 2016 - دوره : 130 - شماره : 4 - صفحه:194 -203
|
چکیده
|
Intrathecal (i.t.) administration of pituitary adenylate cyclase-activating polypeptide (pacap) induces long-lasting nociceptive behaviors for more than 60 min in mice,while the involvement of pacap type1 receptor (pac1-r) has not been clarified yet. the present study investigated signaling mechanisms of the pacap-induced prolonged nociceptive behaviors. single i.t. injection of a selective pac1-r agonist,maxadilan (max),mimicked nociceptive behaviors in a dose-dependent manner similar to pacap. pre- or post-treatment of a selective pac1-r antagonist,max.d.4,significantly inhibited the nociceptive behaviors by pacap or max. coadministration of a protein kinase a inhibitor,rp-8-br-camps,a mitogen-activated protein kinase/extracellular signal-regulated kinase (erk) kinase inhibitor,pd98059 or a c-jun n-terminal kinase (jnk) inhibitor,sp600125,significantly inhibited the nociceptive behaviors by max. immunohistochemistry and immunoblotting analysis revealed that spinal administration of max-induced erk phosphorylation and jnk phosphorylation,and also augmented an astrocyte marker,glial fibrillary acidic protein in mouse spinal cord. furthermore,an astroglial toxin,l-α-aminoadipate,significantly attenuated the development of the nociceptive behaviors and erk phosphorylation by max. these results suggest that the activation of spinal pac1-r induces long-lasting nociception through the interaction of neurons and astrocytes. © 2016 the authors.
|
کلیدواژه
|
c-Jun N-terminal kinase (JNK); Extracellular signal-regulated kinase (ERK); Glial fibrillary acidic protein (GFAP); PACAP type1 (PAC1) receptor (PAC1-R); Pituitary adenylate cyclase-activating polypeptide (PACAP)
|
آدرس
|
department of pharmacology,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544,japan,department of anesthesiology and critical care medicine,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of pharmacology,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of pharmacology,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of anesthesiology and critical care medicine,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of pharmacology,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of pharmacology,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of pharmacology,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of anesthesiology and critical care medicine,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan, department of pharmacology,graduate school of medical and dental sciences,kagoshima university,8-35-1 sakuragaoka,kagoshima city,kagoshima,890-8544, Japan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|